Its overexpression is associated with poor cancer patients’ survival, as it may regulate cell cycle mitosis, mitotic G1/S phase, mitotic G2/M phase, Rb-1 pathway, M phase, IL-10 signalling, pathways via regulation of TP53 and P53 activity [50]. Here, TP53 is linked to cancer.